Inflazome has a total of 434 patents globally, out of which 71 have been granted. Of these 434 patents, more than 51% patents are active. United Kingdom is where Inflazome has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, United Kingdom seems to be the main focused R&D centre and Ireland is the origin country of Inflazome.
Inflazome, founded in 2016 and headquartered in Dublin, Ireland, is a biotech company developing oral drugs that target inflammasomes to treat chronic inflammatory diseases. By blocking inflammasome signals, its therapies aim to address the root cause of conditions such as Parkinson’s, Alzheimer’s, atherosclerosis, and type 2 diabetes. Specialties include biopharma, biotechnology, and health diagnostics.
Do read about some of the most popular patents of Inflazome which have been covered by us in this article and also you can find Inflazome patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Inflazome patent portfolio.
How many patents does Inflazome have?
Inflazome has a total of 434 patents globally. These patents belong to 35 unique patent families. Out of 434 patents, 222 patents are active.
How Many Patents did Inflazome File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Inflazome Applications Filed | Inflazome Patents Granted |
| 2025 | 1 | 4 |
| 2024 | 3 | 18 |
| 2023 | 3 | 14 |
| 2022 | 10 | 13 |
| 2021 | 20 | 9 |
| 2020 | 93 | 13 |
| 2019 | 147 | – |
| 2018 | 138 | – |
| 2017 | 19 | – |
How many Inflazome patents are Alive/Dead?
Worldwide Patents
How Many Patents did Inflazome File in Different Countries?
Countries in which Inflazome Filed Patents
| Country | Patents |
| United Kingdom | 72 |
| Europe (EPO) | 41 |
| United States of America | 41 |
| Hong Kong (S.A.R.) | 22 |
| Japan | 22 |
| China | 21 |
| Australia | 10 |
| Korea (South) | 9 |
| Mexico | 9 |
| Brazil | 9 |
| Canada | 9 |
| Israel | 9 |
| Singapore | 8 |
| Taiwan | 7 |
| Russia | 7 |
| India | 7 |
| Malaysia | 7 |
| South Africa | 7 |
| Pakistan | 7 |
| Argentina | 7 |
| Uruguay | 6 |
| Chile | 5 |
| Peru | 5 |
| Germany | 3 |
| Macao | 3 |
| Poland | 2 |
| Slovakia | 2 |
| Spain | 2 |
| Slovenia | 2 |
| Serbia | 2 |
| Denmark | 2 |
| Morocco | 2 |
| Croatia | 2 |
| Norway | 2 |
| Colombia | 2 |
| Viet Nam | 2 |
| Austria | 2 |
| Portugal | 2 |
| Lithuania | 2 |
| Hungary | 2 |
| Philippines | 2 |
| Costa Rica | 2 |
| Montenegro | 1 |
| Cyprus | 1 |
| Malta | 1 |
| Indonesia | 1 |
| Republic of Moldova | 1 |
| Albania | 1 |
| New Zealand | 1 |
Where are Research Centres of Inflazome Patents Located?
10 Best Inflazome Patents
WO2019008025A1 is the most popular patent in the Inflazome portfolio. It has received 108 citations so far from companies like Pfizer, Roche & Hoechst.
Below is the list of 10 most cited patents of Inflazome:
| Publication Number | Citation Count |
| WO2019008025A1 | 108 |
| WO2019034690A1 | 88 |
| WO2019034686A1 | 88 |
| WO2019068772A1 | 83 |
| WO2019034693A1 | 73 |
| WO2019008029A1 | 70 |
| WO2019034692A1 | 68 |
| WO2019092170A1 | 66 |
| WO2019034696A1 | 66 |
| WO2019034697A1 | 64 |
What Percentage of Inflazome US Patent Applications were Granted?
Inflazome (Excluding its subsidiaries) has filed 43 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 20 have been granted leading to a grant rate of 90.91%.
Below are the key stats of Inflazome patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Inflazome?
| Law Firm | Total Applications | Success Rate |
| Alston & Bird Llp | 42 | 90.91% |
| Genentech Inc | 1 | 0% |
What are Inflazome key innovation segments?
What Technologies are Covered by Inflazome?
The chart below distributes patents filed by Inflazome in different countries on the basis of the technology protected in patents. It also represents the markets where Inflazome thinks it’s important to protect particular technological inventions.
R&D Focus: How has Inflazome search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Inflazome?
